Stocklytics Platform
Asset logo for symbol NXLIW
Nexalin Technology
NXLIW5
$0.52arrow_drop_down3.46%-$0.02
Penny Stock
Asset logo for symbol NXLIW
NXLIW5

$0.52

arrow_drop_down3.46%

Performance History

Chart placeholder
Key Stats
Open$0.58
Prev. Close$0.58
EPS-
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$0.00
PE Ratio-
LOWHIGH
Day Range0.58
0.87
52 Week Range0.00
0.87
Ratios
Revenue-
EBITDA Margin %-
EPS-

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

About Nexalin Technology (NXLIW)

Nexalin Technology, Inc. (NXLIW) is an innovative company that specializes in the development and commercialization of advanced technology solutions. With a focus on improving the well-being of individuals, the company has gained recognition for its groundbreaking products and services. NXLIW stock price history has shown positive growth over the years, reflecting investors' confidence in the company. The stock has experienced fluctuations in line with market trends but has generally performed well. As of the latest data available, the stock is trading at a steady price, indicating stability in the market.
Nexalin Technology, Inc. continues to make headlines with its advancements in the field of technology. The company's dedication to research and development is evident in its constant strive for innovation. Recent news surrounding NXLIW has highlighted its latest product launch, which has been well-received by both consumers and industry experts. This positive reception has contributed to an increase in market interest, with investors showing a keen interest in the company's future prospects.
Websitecall_made
Sector
Industry
CEO
Headquarters
Employees
0
Exchange
NASDAQ
add Nexalin Technology to watchlist

Keep an eye on Nexalin Technology

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Nexalin Technology's (NXLIW) price per share?

The current price per share for Nexalin Technology (NXLIW) is $0.53. The stock has seen a price change of -$0.02 recently, indicating a -3.46% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Nexalin Technology (NXLIW)?

For Nexalin Technology (NXLIW), the 52-week high is $0.88, which is 66.35% from the current price. The 52-week low is $0.01, the current price is 7.41K% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Nexalin Technology (NXLIW) a growth stock?

Nexalin Technology (NXLIW) has shown an average price growth of -6.8% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Nexalin Technology as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Nexalin Technology (NXLIW) stock price performance year to date (YTD)?

As of the latest data, Nexalin Technology (NXLIW) has a year-to-date price change of . Over the past month, the stock has experienced a price change of 289.63%. Over the last three months, the change has been 275.71%. Over the past six months, the figure is 381.24%.
help

Is Nexalin Technology (NXLIW) a profitable company?

Nexalin Technology (NXLIW) has a net income of -$4.65M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 76.8% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -4.83K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $85.06K. Operating income is noted at -$5.7M. Furthermore, the EBITDA is -$6.4M.
help

What is the market capitalization of Nexalin Technology (NXLIW)?

Nexalin Technology (NXLIW) has a market capitalization of $0. The average daily trading volume is 0.87, indicating the stock's liquidity and investor engagement.

News

Nexalin Technology Announces Closing of $5.2 Million Public Offering
ADVISORY
Jul 1, 2024

Nexalin Technology Announces Closing of $5.2 Million Public Offering

Nexalin Technology Announces Pricing of $5.2 Million Public Offering
INITIAL PUBLIC OFFERINGS
Jun 28, 2024

Nexalin Technology Announces Pricing of $5.2 Million Public Offering

Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer’s and Dementia
ADVISORY
Jun 20, 2024

Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer’s and Dementia

Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)
ADVISORY
PRODUCT / SERVICES ANNOUNCEMENT
Jun 13, 2024

Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)

FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset Device
ADVISORY
CLINICAL STUDY
Jun 3, 2024

FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset Device

Nexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research Efforts
ADVISORY
May 22, 2024

Nexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research Efforts

Take Your Investments to a Whole New Level